These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 24875431)

  • 21. Psychiatric comorbidity in hospitalized adolescents with borderline personality disorder.
    Ha C; Balderas JC; Zanarini MC; Oldham J; Sharp C
    J Clin Psychiatry; 2014 May; 75(5):e457-64. PubMed ID: 24922498
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Factors associated with high use of public mental health services by persons with borderline personality disorder.
    Comtois KA; Russo J; Snowden M; Srebnik D; Ries R; Roy-Byrne P
    Psychiatr Serv; 2003 Aug; 54(8):1149-54. PubMed ID: 12883144
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Borderline personality disorder: health service use and social functioning among a national household population.
    Coid J; Yang M; Bebbington P; Moran P; Brugha T; Jenkins R; Farrell M; Singleton N; Ullrich S
    Psychol Med; 2009 Oct; 39(10):1721-31. PubMed ID: 19250579
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Borderline personality disorder and traits in veterans: psychiatric comorbidity, healthcare utilization, and quality of life along a continuum of severity.
    Black DW; Blum N; Letuchy E; Carney Doebbeling C; Forman-Hoffman VL; Doebbeling BN
    CNS Spectr; 2006 Sep; 11(9):680-9; quiz 719. PubMed ID: 16946693
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A naturalistic longitudinal study of extended inpatient treatment for adults with borderline personality disorder: An examination of treatment response, remission and deterioration.
    Fowler JC; Clapp JD; Madan A; Allen JG; Frueh BC; Fonagy P; Oldham JM
    J Affect Disord; 2018 Aug; 235():323-331. PubMed ID: 29665515
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A Markov model for predicting levels of psychiatric service use in borderline and antisocial personality disorders and bipolar type II affective disorder.
    Perry JC; Lavori PW; Hoke L
    J Psychiatr Res; 1987; 21(3):215-32. PubMed ID: 3681758
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prevalence rates of childhood protective factors in adolescents with BPD, psychiatrically healthy adolescents and adults with BPD.
    Borkum DB; Temes CM; Magni LR; Fitzmaurice GM; Aguirre BA; Goodman M; Zanarini MC
    Personal Ment Health; 2017 Aug; 11(3):189-194. PubMed ID: 28556522
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Experiences of care by Australians with a diagnosis of borderline personality disorder.
    Lawn S; McMahon J
    J Psychiatr Ment Health Nurs; 2015 Sep; 22(7):510-21. PubMed ID: 26122817
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Is borderline personality disorder only a mental health problem?
    Cailhol L; Francois M; Thalamas C; Garrido C; Birmes P; Pourcel L; Lapeyre-Mestre M; Paris J
    Personal Ment Health; 2016 Nov; 10(4):328-336. PubMed ID: 27735136
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Maladaptive interpersonal schemas as sensitive and specific markers of borderline personality disorder among psychiatric inpatients.
    Cohen LJ; Tanis T; Ardalan F; Yaseen Z; Galynker I
    Psychiatry Res; 2016 Aug; 242():395-403. PubMed ID: 27394052
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Psychosocial impairment and treatment utilization by patients with borderline personality disorder, other personality disorders, mood and anxiety disorders, and a healthy comparison group.
    Ansell EB; Sanislow CA; McGlashan TH; Grilo CM
    Compr Psychiatry; 2007; 48(4):329-36. PubMed ID: 17560953
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Risk stratification for the early diagnosis of borderline personality disorder using psychiatric co-morbidities.
    Shen CC; Hu LY; Tsai SJ; Yang AC; Chen PM; Hu YH
    Early Interv Psychiatry; 2018 Aug; 12(4):605-612. PubMed ID: 27587229
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Diagnostic accuracy of the McLean Screening Instrument for borderline personality disorder in an inpatient sample who seek a disorder-specific treatment].
    Kröger C; Huget F; Roepke S
    Psychother Psychosom Med Psychol; 2011 Nov; 61(11):481-6. PubMed ID: 22081467
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clinical management for hospital-treated deliberate self-poisoning: comparisons between patients with major depression and borderline personality disorder.
    Carter GL; Lewin TJ; Stoney C; Whyte IM; Bryant JL
    Aust N Z J Psychiatry; 2005 Apr; 39(4):266-73. PubMed ID: 15777364
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Ten-year use of mental health services by patients with borderline personality disorder and with other axis II disorders.
    Hörz S; Zanarini MC; Frankenburg FR; Reich DB; Fitzmaurice G
    Psychiatr Serv; 2010 Jun; 61(6):612-6. PubMed ID: 20513685
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Psychopharmacotherapy in adolescents with borderline personality disorder in inpatient and outpatient psychiatric treatment].
    Wöckel L; Goth K; Matic N; Zepf FD; Holtmann M; Poustka F
    Z Kinder Jugendpsychiatr Psychother; 2010 Jan; 38(1):37-49. PubMed ID: 20047175
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Treatment histories of borderline inpatients.
    Zanarini MC; Frankenburg FR; Khera GS; Bleichmar J
    Compr Psychiatry; 2001; 42(2):144-50. PubMed ID: 11244151
    [TBL] [Abstract][Full Text] [Related]  

  • 38. PRO*BPD: effectiveness of outpatient treatment programs for borderline personality disorder: a comparison of Schema therapy and dialectical behavior therapy: study protocol for a randomized trial.
    Fassbinder E; Assmann N; Schaich A; Heinecke K; Wagner T; Sipos V; Jauch-Chara K; Hüppe M; Arntz A; Schweiger U
    BMC Psychiatry; 2018 Oct; 18(1):341. PubMed ID: 30340474
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Differences between older and younger adults with borderline personality disorder on clinical presentation and impairment.
    Morgan TA; Chelminski I; Young D; Dalrymple K; Zimmerman M
    J Psychiatr Res; 2013 Oct; 47(10):1507-13. PubMed ID: 23866737
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The validity of the MSI-BPD among inpatient adolescents.
    Noblin JL; Venta A; Sharp C
    Assessment; 2014 Apr; 21(2):210-7. PubMed ID: 23344914
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.